Navigation Links
MedCath Corporation Reports Fourth Quarter Earnings
Date:11/11/2009

fiscal year ended September 30, 2008. Adjusted EBITDA was $55.6 million, and loss from continuing operations was ($58.4) million for fiscal 2009 compared to $74.8 million and $12.4 million, respectively for fiscal 2008. EPS was ($2.98) per diluted share for fiscal 2009 compared to $0.61 per diluted share for fiscal 2008.

MedCath's fiscal year 2009 results include the impact of certain items that collectively had a $4.5 million negative impact to net revenue, a $12.8 million negative impact to Adjusted EBITDA and a $(3.65) impact to EPS from continuing operations.

MedCath's fiscal year 2008 actual results include the impact of certain items that collectively had a $1.4 million negative impact to net revenue, a $7.6 million negative impact to Adjusted EBITDA and a $(0.21) impact to EPS from continuing operations.

Share-based compensation expense totaled $2.4 million in fiscal 2009, compared to $5.0 million in fiscal 2008. Adjusted EBITDA disclosed above does not include this expense but the expense is included as a component of (loss) income from continuing operations.

Fiscal Year Operating Statistics, Cash Flow and Capital Expenditures

Same facility hospital admissions for fiscal 2009 were 26,856, down 8.3% compared with fiscal 2008. Adjusted admissions totaled 40,964, up 0.2% compared with fiscal 2008. Same facility hospital outpatient cases totaled 61,383 in fiscal 2009, up 11.5% in comparison with fiscal 2008.

Total uncompensated care, which includes charity care plus bad debt expense, equaled 9.6% of hospital division net patient revenue before the deduction for charity care for fiscal 2009 versus 10.1% for fiscal 2008.

Net cash provided by operating activities of continuing operations for fiscal 2009 increased 48.8% to $64.3 million from $43.2 million in the fourth quarter of fiscal 2008. Cash paid for capital expenditures during fiscal 2009 totaled $93.9 million, whic
'/>"/>

SOURCE MedCath Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related medicine technology :

1. MedCath Corporation to Hold Conference Call on Fourth Quarter Results
2. Webcast Alert: Isis Pharmaceuticals and Genzyme Corporation to Present Mipomersen Phase 3 Data in HoFH During AHA
3. Dr. John Mills and Joseph Gentile Join Board of Directors of ChanTest Corporation
4. Volcano Corporation Presentation at Canaccord Adams Conference to Be Webcast
5. Raptor Pharmaceutical Corporation Announces Presentation of Data for NGX426, a Novel, Non-Opioid Oral Analgesic, at Neuropathic Pain Conference
6. China National Medicines Corporation Issues Milestone Purchase Order for 12,000 STA Systems
7. China Medicine Corporation to Acquire Pharmaceutical Manufacturer in Guangzhou
8. DURECT Corporation Invites You to Join its Third Quarter 2009 Earnings Conference Call
9. Volcano Corporation Schedules Third Quarter Conference Call, Webcast
10. Cephalon Signs Option Agreement to Acquire BioAssets Development Corporation
11. Select Medical Holdings Corporation Announces Exercise of Underwriters Option to Purchase Additional Shares
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... DUBLIN , May 27, 2015 /PRNewswire/ ... ) has announced the addition of the  ... Testing Market"  report to their offering.  ... ,This comprehensive five-country report contains 500 pages, ... current suppliers and potential market entrants identify ...
(Date:5/27/2015)... May 27, 2015 OpportunityAnalyzer: Sepsis - Opportunity ... patients suffer from a series of diverse complications arising ... the blood or tissues, which cause a rapidly progressing ... mortality rates near 50% depending on disease severity. The ... systems of the global marketplace, which for the purposes ...
(Date:5/27/2015)... PharmaPoint: Type 1 Diabetes - Global Drug Forecast and Market ... is an autoimmune disease that permanently destroys beta cells of ... longer produce insulin. Over the last 90 years, insulin therapy ... can be offered to a patient who is newly diagnosed ... of action - long-acting as well as short or rapid-acting ...
Breaking Medicine Technology:European Hemostasis Diagnostic Testing Market Strategies 2015 2OpportunityAnalyzer: Sepsis - Opportunity Analysis and Forecasts to 2021 2OpportunityAnalyzer: Sepsis - Opportunity Analysis and Forecasts to 2021 3OpportunityAnalyzer: Sepsis - Opportunity Analysis and Forecasts to 2021 4PharmaPoint: Type 1 Diabetes - Global Drug Forecast and Market Analysis to 2023 2PharmaPoint: Type 1 Diabetes - Global Drug Forecast and Market Analysis to 2023 3PharmaPoint: Type 1 Diabetes - Global Drug Forecast and Market Analysis to 2023 4
... CITY, Calif., July 7 Relievant Medsystems, Inc., developer ... back pain, reported today that it has completed a ... led by Morgenthaler Ventures with existing investors Canaan Partners ... participating. The company also announced that Morgenthaler partner ...
... Sanofi-aventis (EURONEXT: SAN and NYSE: SNY ... study of Lantus(R) (insulin glargine [rDNA] injection) versus NPH insulin ... published on-line in Diabetologia ... in the two treatment groups. This is the longest controlled ...
Cached Medicine Technology:Relievant Medsystems Announces Completion of $20 Million Financing 2Relievant Medsystems Announces Completion of $20 Million Financing 35-Year Study Published in Diabetologia Demonstrated Long-Term Safety of Lantus(R) Compared to NPH 25-Year Study Published in Diabetologia Demonstrated Long-Term Safety of Lantus(R) Compared to NPH 35-Year Study Published in Diabetologia Demonstrated Long-Term Safety of Lantus(R) Compared to NPH 45-Year Study Published in Diabetologia Demonstrated Long-Term Safety of Lantus(R) Compared to NPH 5
(Date:5/28/2015)... May 28, 2015 Although many people ... stuck with their slow metabolism for life, never being ... is not true. There are methods to jump start ... advertisements for low-carbohydrate, low-fat and no-fat foods, cleverly worded ... healthy, many times the foods contain hidden ingredients and ...
(Date:5/28/2015)... Texas (PRWEB) May 28, 2015 ... an updated version of his patient education website ... website redesign allows patients to readily access current ... erectile dysfunction treatment, male urinary incontinence, prostate cancer ... goal of this website is to educate patients ...
(Date:5/28/2015)... 28, 2015 SpendWell Health, an e-commerce ... has been named a “Cool Vendor” by Gartner in ... in Healthcare Payers, 2015 by Jeff Cribbs, Constance ... highlights innovative vendors, products and services in health care ... the health care payer market. , SpendWell’s solution ...
(Date:5/28/2015)... Sunshine Coast Health Center, one of ... at http://www.sunshinecoasthealthcentre.ca , is proud to announce ... the Toronto, Ontario, community. The company has a ... its online location information for Toronto residents. , ... we realize that addiction impacts family and friends," ...
(Date:5/28/2015)... The Cancer Solution: Taking Charge of ... researched and heartfelt book the Booksandauthor reviewer ever ... for writing what should be one of the most ... there is power in action and this book has both. ... to talk about and unfortunately many persons know little about ...
Breaking Medicine News(10 mins):Health News:As Part of their Comprehensive Weight Loss Program, Diet Doc Now Teaches Patients how to Identify Hidden Carbohydrates for Safe, Fast and Long Term Weight Loss Success 2Health News:As Part of their Comprehensive Weight Loss Program, Diet Doc Now Teaches Patients how to Identify Hidden Carbohydrates for Safe, Fast and Long Term Weight Loss Success 3Health News:As Part of their Comprehensive Weight Loss Program, Diet Doc Now Teaches Patients how to Identify Hidden Carbohydrates for Safe, Fast and Long Term Weight Loss Success 4Health News:Mark Allen MD, Dallas Urologist, Launches Updated Patient Education Website With a Focus on Prostate Cancer and Erectile Dysfunction Treatment 2Health News:SpendWell Named a “Cool Vendor” by Gartner 2Health News:SpendWell Named a “Cool Vendor” by Gartner 3Health News:SpendWell Named a “Cool Vendor” by Gartner 4Health News:Toronto Alcohol Treatment and Drug Rehab Local Information Page Updated, Announces Sunshine Coast Health Center 2Health News:Toronto Alcohol Treatment and Drug Rehab Local Information Page Updated, Announces Sunshine Coast Health Center 3Health News:Booksandauthor Cites The Cancer Solution as One of the Most Important Books to Read 2
... in teen, adult females, but not in men, study ... is associated with delayed childbearing in women, according to ... of alcohol dependence and their age when they had ... from two groups of Australian twins born between 1893-1964 ...
... Co., Inc. (OTC Bulletin Board: TYNP, TYNPE), a ... based in,Chengdu, China, today announced that the Company,s ... TYNPE due to the electronic eligibility,system error., ... Company expects the,stock symbol to trade under the ...
... Edward,G. Rendell today said Pennsylvania,s agricultural industry is ... system, underscoring the need,to secure the state,s energy ... Nearly 900 guests gathered to hear the ... at Ag Progress Days, Pennsylvania,s,largest outdoor agricultural exposition., ...
... (MGH) investigators have found that infusions of a particular ... from autoimmune attack in a mouse model. In ... , the team from the MGH Center for Engineering ... to control several immune system activities, allowed the regeneration ...
... Four Girls to My Beauty Camp ... this ... with the popular teenage Web site ELLEgirl.com to send four contest,winners later ... the new school year approaching, the goal of the camp is,to empower ...
... FALLS CHURCH, Va., Aug. 20 Scientists,physicians, ... Food,and Drug Administration,s (FDA) announcement that bisphenol A ... products including can,linings and baby bottles - is ... obesity, developmental problems, risk for heart,attack, and breast ...
Cached Medicine News:Health News:Women's Alcohol Use Tied to Delayed Childbearing 2Health News:Tianyin Pharmaceutical Co., Inc. Announces Trading Symbol Error and Correction 2Health News:Pennsylvania Governor Rendell Highlights Renewable Energy, Health Care Reform at Ag Progress Days 2Health News:Bone marrow stem cells may help control inflammatory bowel disease 2Health News:Bone marrow stem cells may help control inflammatory bowel disease 3Health News:Special Summer Camp Helps Girls Recognize Inner and Outer Beauty 2Health News:Special Summer Camp Helps Girls Recognize Inner and Outer Beauty 3Health News:Special Summer Camp Helps Girls Recognize Inner and Outer Beauty 4Health News:Special Summer Camp Helps Girls Recognize Inner and Outer Beauty 5Health News:FDA Decision on BPA Outrages Health Advocates 2Health News:FDA Decision on BPA Outrages Health Advocates 3
... breadth of infectious disease ELISA products make ... standard assay protocols for faster integration into ... products provide increased reliability and run-to-run consistency. ... detection assays for a wide range of ...
... ELISA products make us a leader in ... faster integration into the busy laboratory, our ... and run-to-run consistency. Our Infectious Disease ELISA ... wide range of serological assays including ToRCH, ...
... Our breadth of infectious disease ELISA ... field. With standard assay protocols for faster ... Disease ELISA products provide increased reliability and ... includes antibody detection assays for a wide ...
... DIFF CHEK-30 is a rapid ELISA ... 100% negative predictive value and 99% sensitivity. ... and cost-effectively screen out C. difficile negatives ... of samples - before culturing for the ...
Medicine Products: